American Society of Clinical Oncology

Androgen receptor abnormality may not be associated

Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). ...

Feb 24, 2015
popularity not rated yet | comments 0

ASCO names Cancer Advance of the Year

The American Society of Clinical Oncology (ASCO) for the first time announced its cancer Advance of the Year: the transformation of treatment for the most common form of adult leukemia. Until now, many patients with chronic ...

Jan 20, 2015
popularity 3.3 / 5 (4) | comments 0

Studies reveal new strategies to improve quality of life

Key studies released today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) identify new strategies for easing the short- and long-term effects of cancer therapy and improving the quality of ...

Jun 02, 2014
popularity not rated yet | comments 0